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Abstract During this study, we have investigated in vitro
activity of N-substituted-3-amino-5-oxo-4-phenyl-2,5-
dihydro-1H-pyrazole-1-carbothioamide derivatives with N-
ethyl, N-(4-metoxyphenyl) and N-cyclohexyl substituents
against Gram-negative Haemophilus influenzae and H. para-
influenzae bacteria. A spectrophotometric assay was used
in order to determine the bacterial growth and biofilm for-
mation using a microtiter plate to estimate minimal inhibi-
tory concentration (MIC) and minimal biofilm inhibitory
concentration (MBIC). Among the tested N-substituted
pyrazole derivatives, only N-ethyl-3-amino-5-oxo-4-phe-
nyl-2,5-dihydro-1H-pyrazole-1-carbothioamide showed a
significant in vitro activity against both planktonic cells of
H. parainfluenzae (MIC = 0.49–31.25 lg ml-1) and H. in-
fluenzae (MIC = 0.24–31.25 lg ml-1) as well as biofilm-
forming cells of H. parainfluenzae (MBIC = 0.24–31.25
lg ml-1) and H. influenzae (MBIC = 0.49 to C31.25
lg ml-1). The pyrazole compound exerted higher inhibitory
effect both on the growth of planktonic cells and biofilm
formation by penicillinase-positive and penicillinase-nega-
tive isolates of H. parainfluenzae than the activity of com-
monly used antibiotics such as ampicillin. No cytotoxicity of
the tested compound in vitro at concentrations used was
found. The tested pyrazole N-ethyl derivative could be
considered as a compound for the design of agents active
against both pathogenic H. influenzae and opportunistic H.
parainfluenzae, showing also anti-biofilm activity. This
appears important because biofilms are determinants of
bacterial persistence in long-term and recurrent infections
recalcitrant to standard therapy.
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Introduction
Biofilms are sessile aggregates of bacterial cells that are
created on either biotic surfaces (e.g., human tissues) or
abiotic surfaces (e.g., biomaterials, catheters) and act like a
single living organism that can exhibit differences in the
expression of surface molecules, antimicrobial resistance,
virulence factors, and pathogenicity (Costerton et al., 1999,
2003; Burmølle et al., 2010; Hall-Stoodley et al., 2012;
Bjarnsholt, 2013). In medicine, biofilms have been widely
associated with several chronic and recurrent diseases,
chronic wound infections, and foreign body infections
associated with implantable medical devices and indwell-
ing catheters, antibiotic-resistant and nearly impossible or
difficult to eradicate without aggressive and long-term
interventional strategies infections (Donlan, 2001; Steward
and Costeron, 2001; Gilbert et al., 2002; Stoodley et al.,
2004; Lasa et al., 2005; Sanclement et al., 2005; Macfar-
lane and Dillon, 2007; Vlastarakos et al., 2007; Macedo
and Abraham, 2009; Wolcott and Ehrlich, 2008; Coenye
and Nelis, 2010; Drago et al., 2012; Bjarnsholt, 2013).
Haemophilus spp. rods, generally known as Gram-neg-
ative microbiota of the upper respiratory tract, are able to
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live as planktonic cells or colonize natural and artificial
surfaces as biofilm-forming cells (Hill et al., 2000; Chin
et al., 2005; Musk and Hergenrother, 2006; Galli et al.,
2007; Kilian, 2007; Moxon et al., 2008; Kosikowska and
Malm, 2009; Murphy et al., 2007; Drago et al., 2012; U¨nal
et al., 2012). Both pathogenic Haemophilus influenzae and
opportunistic H. parainfluenzae can cause acute, chronic,
invasive or non-invasive infections. These microorganisms
may form a biofilm which is a virulence determinant which
contributes to recurrent or chronic infections. H. influenzae
is the most pathogenic bacteria colonizing the mucous
membranes of the respiratory tract of young children or
sporadically elderly people. H. influenzae, mainly serotype
b (Hib), is frequently associated with different diseases,
e.g., otitis media, chronic bronchitis, and pneumonia
(Agrawal and Murphy, 2011). Other illnesses caused by
this species include osteomyelitis, arthritis, sepsis, phleg-
mon cellulitis, or abscesses. Non-typeable H. influenzae
(NTHi) is one of the main causes of airway infection in
chronic obstructive pulmonary disease, of recurrent otitis
media in infants and children, sinusitis in children and
adults, pneumonia in adults, lower respiratory tract infec-
tion in adults, and recurrent respiratory tract infections in
patients with chronic bronchitis (Murphy, 2003; Erwin and
Smith, 2007).
Haemophilus parainfluenzae is an opportunistic pathogen,
which may cause several endogenous diseases occasionally
and under predisposing conditions (e.g., chronic diseases or
immune disorders) such as respiratory tract infections, endo-
carditis, biliary tract infection, septic arthritis, thoracic empy-
ema, meningitis, secondary bacteremia, urethritis, and hepatic
abscesses (Chow et al., 1974; Cooney et al., 1981; Warman
et al.; 1981; Raoult et al., 1987; Darras-Joly et al., 1997; Das
et al., 1997; Bottone and Zhang,1995; Pillai et al., 2000;
Frankard et al., 2004; Cardines et al., 2009).
Nitrogen heterocycles, including pyrazoles, are important
group of natural or synthetic derivatives with a broad spectrum
of biological and pharmaceutical activities, e.g., antibacterial,
antifungal, antiviral, anti-inflammatory, antipyretic, antican-
cer, and anticonvulsant (Comber et al., 1991; Mahajan et al.,
1991; Chauhan et al., 1993; Sugiura et al. 1977; Bekhit and
Abdel-Aziem, 2004; Go¨khan-Kelekc¸i et al., 2007; Lin et al.,
2007; Kumar et al., 2012). Much attention has been paid to
pyrazole derivatives due to their wide range of antibacterial
activities as potential and selective inhibitors against DNA
gyrase capable of causing bacterial cells’ death (Reece and
Maxwell, 1991; Maxwell, 1997; Tanitame et al., 2004; Liu
et al., 2008; Shiroya et al., 2011). N-ethyl-3-amino-5-oxo-4-
phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide, synthe-
sized according to Pitucha et al. (2010) appears to be a
promising precursor of agents with good activity mainly
against Gram-positive bacteria––both pathogenic, including
Staphylococcus aureus (MIC = 7.81–62.5 lg ml-1) as well
as opportunistic, e.g., S. epidermidis, Bacillus spp. or Micro-
coccus luteus with MIC = 3.91–31.25 lg ml-1 (Pitucha
et al., 2010). The inhibitory effect against Gram-negative
bacteria––belonging to Enterobacteriaceae family (Esche-
richia coli, Klebsiella pneumoniae, and Proteus mirabilis)
or nonfermentative rods (Pseudomonas aeruginosa) was
weaker (MIC = 250–1,000 lg ml-1). In this paper, we have
investigated in vitro activity of pyrazole derivatives, among
which N-ethyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-
pyrazole-1-carbothioamide showed highest activity against
planktonic and biofilm-forming cells of H. influenzae and H.
parainfluenzae.
Results and discussion
According to our preliminary results, N-(4-metoxyphenyl)-
3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-car-
bothioamide compound had very low inhibitory effect on
the growth of planktonic cells of the reference strains of
Haemophilus spp. (MIC = 500–1,000 lg ml-1), similar
to N-cyclohexyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-
pyrazole-1-carbothioamide which inhibited the growth of
these bacteria with somewhat lower MIC = 125–500
lg ml-1. Among the tested pyrazole derivatives, N-ethyl-
3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbo-
thioamide derivative showed a significant in vitro potency
against the growth of planktonic cells of the tested Hae-
mophilus spp. strains with MIC \62.5 lg ml-1.
As shown in Table 1, detailed studies with N-ethyl-3-
amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothio-
amide revealed that this compound possessed good activity
against planktonic cells of the reference strains of H. para-
influenzae ATCC 7901 (MIC = 0.49 lg ml-1), H. para-
influenzae ATCC 51505 (MIC = 7.81 lg ml-1), and H.
influenzae ATCC 10211 (MIC = 0.49 lg ml-1). This
compound was also active against planktonic cells of 20
clinical isolates of H. parainfluenzae (MIC = 1.95–31.25
lg ml-1) and of 11 clinical isolates of H. influenzae
(MIC = 0.24–31.25 lg ml-1). Moreover, the activity of
the tested compound against H. parainfluenzae and H. in-
fluenzae biofilm-forming cells was also determined––it
inhibited biofilm formation by reference strains of
H. parainfluenzae ATCC 7901 (minimal biofilm inhibitory
concentration [MBIC] = 1.95 lg ml-1) and H. parainflu-
enzae ATCC 51505 (MBIC = 15.63 lg ml-1) or by 20
clinical isolates of H. parainfluenzae (MBIC = 0.24–31.25
lg ml-1). The tested compound showed the inhibitory
effect against biofilm-forming cells of H. influenzae ATCC
10211 (MBIC = 15.63 lg ml-1) or seven H. influenzae
clinical isolates (MBIC = 0.49–31.25 lg ml-1). In case of
four clinical isolates of H. influenzae, MBIC were found to
be [31.25 lg ml-1.
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To determine the power of the tested compound as an
anti-biofilm agent, the MBIC/MIC ratio was assessed. The
most frequently MBIC/MIC ratio ranged from 0.5 to
2 lg ml-1, indicating comparable activity of the com-
pound either against planktonic or biofilm-forming cells of
H. parainfluenzae and H. influenzae (Fig. 1). Only in some
cases, MBIC/MIC ratio was lower for H. parainfluenzae
and was higher for H. influenzae, indicating strain- and
species-dependent activity of the tested compound.
Figure 2 shows the activity of N-ethyl-3-amino-5-oxo-4-
phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide on the
growth or biofilm formation by penicillinase-negative
(S85Pen-) and penicillinase-positive (S86Pen?) H. para-
influenzae. In the case of penicillinase-positive isolate, the
activity of the compound was significantly higher both on
the growth and on the biofilm formation.
The in vitro cytotoxicity of the tested N-ethyl-3-amino-5-
oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide com-
pound was presented as percentage viability of vero cells
used as an experimental model. According to the results
shown in Table 2, after 48 h of incubation, no cytotoxic
effect was observed up to 200 lg ml-1 concentration of the
tested compound. The most widely used as a measurement of
compound’s toxicity is the half maximal effective concen-
tration (EC50), as the concentration of the compound where
50 % of its maximal effect is observed; in case of the tested
compound EC50 = 278.8 lg ml
-1. This means that this
compound was not toxic to eukaryotic cells at concentrations
exerting inhibitory effect against Haemophilus spp.,
including anti-biofilm activity.
Although the control of bacterial infections has been
effective since the discovery of antimicrobial drugs, wide-
spread drug resistance among bacteria has led to a search for
new antibacterial agents. However, the finding of biofilm
phenotype bacteria, showing usually intrinsic insensitivity to
available drugs at standard dosing effective against plank-
tonic cells, has created a necessity to pay more attention to
targeted anti-biofilm agents. In this work, we have found that
the N-ethyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyr-
azole-1-carbothioamide possessed good in vitro activity
either against free-floating (planktonic) or biofilm-forming
cells of Haemophilus spp. Haemophili rods, e.g., pathogenic
H. influenzae or opportunistic H. parainfluenzae are found to
be a part of proper microflora of the upper respiratory tract
(Kilian, 2007; Murphy et al., 2007). Under favorable con-
ditions, these bacterial species may be the etiologic agents of
various and unspecified infections, including those associ-
ated with biofilm formation (Trollfors et al., 1985; Black
et al., 1988; Mitchell and Hill, 2000; Chin et al., 2005; Musk
and Hergenrother, 2006; Rele et al., 2006; Galli et al., 2007;
Moxon et al., 2008; Cardines et al., 2009; Drago et al., 2012;
Bjarnsholt, 2013). It has been estimated that the biofilms
protect microbes from the immune system, antimicrobials,
predation or stresses, and are crucial for the development of
recurrent and opportunistic diseases (Costerton et al., 1999,
Table 1 The effect of N-ethyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-
1H-pyrazole-1-carbothioamide on the growth of Haemophilus spp.
planktonic (MIC) or biofilm-forming (MBIC) cells
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Fig. 1 The effect of N-ethyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-
1H-pyrazole-1-carbothioamide compound on biofilms formation by
Haemophilus spp. on the basis of MBIC/MIC ratio
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2003; Donlan, 2002; Prakash et al., 2003; Jain et al., 2007;
Wolcott and Ehrlich, 2008).
The pyrazole derivatives are potent and selective inhibi-
tors against DNA gyrase (Reece and Maxwell, 1991; Tani-
tame et al., 2004; Tse-Dinh, 2007; Farag et al. 2008; Liu
et al., 2008; Shiroya et al., 2011). Considering a possible
mechanism of anti-biofilm activity of N-ethyl-3-amino-5-
oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide, it
should be noted that several classes of chemical compounds,
e.g., pyrazole or thioamide derivatives, may act as quorum-
sensing inhibitors (Hentzer and Givskov, 2003; Schillaci
et al. 2008; Brackman et al., 2009; Kociolek, 2009; Oancea,
2010). Quorum-sensing phenomenon, which is one of the
ways to control biofilms, is a chemical form of bacterial
communication via signaling molecules essential for bacte-
rial communities to regulate the group and to synchronize
the behavior (Hastings and Greenberg, 1999; Van Houdt
et al., 2004; Raffa et al., 2005; Waters and Bassler, 2005;
Musk and Hergenrother, 2006; Bjarnsholt and Givskov,
2007; Amer et al., 2008; Labandeira-Rey et al., 2009; Deep
et al., 2011). In agreement with the data provided by the
literature, pyrazole compounds may act as inhibitors that
target this cell–cell signaling mechanism (Tanitame et al.,
2004; Musk and Hergenrother, 2006; Tse-Dinh, 2007;
Schillaci et al., 2008; Brackman et al., 2009; Oancea, 2010).
The number of literature data dealing with regulatory
mechanisms controlling the haemophili biofilm formation
and a possible effect of different chemical compounds on
this process is strongly limited. In our opinion, comparable
activity of the tested compound having the ethyl substituent
against planktonic or biofilm-forming cells of haemophili
rods may be due to the dual activity of pyrazole––main
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Table 2 The effect of N-ethyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-
1H-pyrazole-1-carbothioamide on vero cells line viability
Compound concentration (lg ml-1) Cell viability (in %) ± SD
x
500 37.95 ± 7.7
200 82.15 ± 5.7
100 89 ± 6.6
50 93.55 ± 4.2
25 97.4 ± 1.7
12.5 98.05 ± 1.8
6.25 98.75 ± 2.0
3.15 100 ± 0.0
0 (control) 100 ± 0.0
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associated with the disorder of quorum-sensing phenomenon
and biofilm formation. We did not find existing studies
dealing with effect of the pyrazole compounds on formation
or eradication of biofilms created by H. influenzae and H.
parainfluenzae.
It should be mentioned that Lux-S family of quorum-
sensing regulatory systems involved in production of au-
toinducer 2 (AI-2), occurring in many bacterial species
and functioning as interspecies signaling system, have
been identified in H. influenzae or H. ducrei (Bassler,
1999; Vendeville et al., 2005; Armbruster et al., 2009;
Swords, 2012). U¨nal et al. (2012) have showed that in
nontypeable H. influenzae, the two-component signaling
system QseB/C was involved in biofilm formation. Daines
et al. (2005) and Armbruster et al. (2009) have observed
the role of LuxS and AI-2 luxS-dependent factors which
control biofilm formation in non-typable H. influenzae,
but they considered as controversial its importance as
virulence factor in pathogenesis of the biofilm-associated
infections.
The change in the structure of the substituent has a
significant impact on the physicochemical properties of the
compound (Hulzebos et al., 2001; Martin et al., 2002). In
our study, we synthesized and tested derivatives differing
from each other by the type of substituents in the thioamide
group. The best results were obtained for the compound
having the ethyl substituent. From the microbiological
point of view, the key factor is the presence of ethyl group
which only slightly increases the mass and the volume of
the compound compared to derivatives with cyclohexyl or
4-metoxyphenyl substituents. Additionally, lower molecu-
lar weight of ethyl derivative can have a significant effect
on the antimicrobial properties of this compound. In our
opinion, replacement of ethyl group on cyclohexyl or
4-metoxyphenyl in the tested pyrazole derivatives causes a
significant decrease of their activity against Haemophilus
spp. Besides, ethyl substituent has a limited conformational
freedom which may affect selectivity (Graham, 2001). This
is very important information from the point of view of the
further modifications of these derivatives and their activity
against either biofilm-forming cells or against mature bio-
film of Haemophilus spp. In addition, further work is
needed to evaluate the role of pyrazole derivatives during
biofilm formation and their influence either on adhesive







carbothioamide were tested against H. influenzae and H.
parainfluenzae in form of planktonic or biofilm-forming cells.
Our study shows that the pyrazoles can be inhibitors acting on
planktonic or biofilm-forming cells of Haemophilus spp.
Additionally, these results allow to expect that this compound
will be the starting substance in the search of antimicrobials
with low toxicity, showing inhibitory effect against Gram-
negative haemophili rods and including anti-biofilm activity.
Further investigations should clarify the mechanism of pyr-





pyrazole-1-carbothioamide derivatives have been screened for
the antibacterial investigations. Obtained compounds were
characterized and described earlier (Pitucha et al., 2010).
N-substituted-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-
pyrazole-1-carbothioamide derivatives were prepared
according to Scheme 1. The starting 1-cyanophenylacetic
acid hydrazide was prepared in the reaction of corre-
sponding ethyl 1-cyanophenylacetate with 80 % hydrazine
hydrate at room temperature. Next, this compound was
converted to the 1-(cyanophenylacetyl-4-subtituted)thio-
semicarbazide in the reaction of 1-cyanophenylacetic acid
hydrazide with ethyl or 4-methoxyphenyl isothiocyanate.
Cyclization of these compounds in alkaline or hydrochloric
acid medium led to appropriate N-substituted-3-amino-5-
oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide.
N-cyclohexyl-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-
pyrazole-1-carbothioamide was obtained in the reaction of
1-cyanophenylacetic acid hydrazide with cyclohexyl iso-
thiocyanate. The reaction was carried out in the diethyl
ether at room temperature without the separation of linear
product.
Bacterial strains
The haemophili reference species from American Type
Culture Collection (ATCC)––H. influenzae ATCC 10211, H.
parainfluenzae ATCC 7901, and H. parainfluenzae ATCC
51505 were included. Besides, 20 clinical isolates of H.
parainfluenzae and 11 clinical isolates of H. influenzae from
the museum of Department of Pharmaceutical Microbiology
of Medical University of Lublin were used.
Med Chem Res (2014) 23:1057–1066 1061
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Growth conditions
The Haemophilus chocolate agar (HAEM, bioMerieux)
medium with PolyVitex and hemoglobin or tripticasein soy
broth (TSB) ? Haemophilus test medium supplement
(HTMS)––TSB (Biocorp) medium supplemented with
HTMS (HTMS SRO158E, Oxoid) with growth factors for
haemophili (25 lg ml-1 of NAD and 15 lg ml-1 of hema-
tin) were used. Chocolate agar is blood agar medium that has
been heated to open the pyrrole ring, forming haemin (a
required growth factor for bacteria lacking hemolysins),
providing optimal growth conditions for H. influenzae and
other fastidious bacteria (Rennie et al., 1992; Han et al.,
2006). In clinical microbiology, the TSB medium is used in a
variety of procedures, e.g., for the microbiological test pro-
cedure of culture media according to the standards (NCLSI,
2000, 2004). However, according to our results, TSB sup-
plemented with HTMS is good as a primary enrichment
medium directly inoculated with the various bacteria (Kos-
ikowska and Malm, 2009). The standardized bacterial sus-
pensions with an optical density of 0.5 McFarland
standard––150 9 106 colony-forming units ml-1 in sterile
0.85 % NaCl were prepared. A stock solutions of
N-substituted-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyra-
zole-1-carbothioamide derivatives at a concentration of
50 mg ml-1 in dimethyl sulfoxide (Sigma) were prepared.
The medium with DMSO at a final concentration and without
the tested compounds served as control––no microbial
growth inhibition was observed.
The bacterial cultures in TSB?HTMS medium with
addition of 30 % glycerol were stored at -70 C. Before
each experiment, bacterial strains were subcultured on
HAEM medium and incubated overnight at 35 C in about
5 % CO2 atmosphere.
Growth assay





azole-1-carbothioamide was screened by the broth micro-
dilution method using 96-well polystyrene microplates
(NUNC, TC MICROWELL 96F Nunclon D) on the basis
of MIC (minimal inhibitory concentration), usually defined
as the lowest concentration of the compounds at which
there was no visible growth of microorganisms. The anti-
bacterial activity was tested according to EUCAST (2003)
procedure with some modifications.
In order to assay the influence of the tested pyrazole
derivatives on the growth of haemophili rods, 198 ll of
TSB?HTMS medium without (control) and with a series of
twofold dilution of the tested compounds in the range of
final concentration from 1,000 to 62.5 lg ml-1 was inoc-
ulated with 2 ll of the standardized microbial suspension
(total volume per each well ––200 ll), and then incubated
for 18 h at 35 C in the presence of about 5 % CO2. Then in
order to assay the influence of the tested N-ethyl-3-amino-5-
oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide
with highest inhibitory effect against the planktonic cells of
Haemophilus spp., 198 ll of TSB?HTMS medium without
(control) and with a series of twofold dilution of the tested
compound in the range of final concentration from 0.12 to
31.25 lg ml-1 was inoculated with 2 ll of the standardized
microbial suspension (total volume per each well––200 ll),
and then incubated for 18 h at 35 C in the presence of
about 5 % CO2. After incubation, spectrophotometric













































Scheme 1 Synthesis and structure of N-substituted-3-amino-5-oxo-4-phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide
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(OD570) of the bacterial cultures with or without the tested
compound were done by using a microplate reader (ELx800
BioTek) in order to determine MIC. The MIC values were
determined by comparison to the growth of a control
(compound-free) medium. Ampicillin was used as a refer-
ence antimicrobial agent on selected H. parainfluenzae
(penicillinase-positive or penicillinase-negative strains)
isolates at the same conditions. The blank control wells
without or with twofold dilution of the tested compounds
added to TSB?HTMS broth without bacterial suspension
were incubated under the same conditions. The experiments
were performed in triplicate.
Biofilm assay
In order to assay the effect of N-ethyl-3-amino-5-oxo-4-
phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide on Hae-
mophilus spp. biofilm formation, the method based on
staining with 0.1 % crystal violet described previously by
Kaplan and Mulks (2005) with some modifications (Kos-
ikowska and Malm, 2009) was used. The activity of the
tested compound against biofilm formation was determined
on the basis of MBIC, defined as the lowest concentration of
the compound at which the biofilm formation was inhibited
(Cˇernohorska´ and Votava, 2008). In order to assay the
influence of the tested compound on the biofilm formation by
haemophili rods, 198 ll of TSB?HTMS medium without
(control) and with a series of twofold dilution of the tested
compound in the range of final concentration from 0.12 to
31.25 lg ml-1 was inoculated with 2 ll of the standardized
microbial suspension (total volume per each well––200 ll),
and then incubated at 35 C in the presence of about 5 %
CO2. After overnight incubation of bacterial culture, the
medium above the culture was decanted and then the plates
were washed extensively several times with distilled water to
remove nonadherent or loosely adherent cells, dried in
inverted position and stained with 200 ll of 0.1 % crystal
violet. The plates were left for 15 min to stain the cells, then
washed extensively under distilled water to remove unbound
dye. Next, in order to elicit a response to each of the wells,
200 ll of isopropyl alcohol (Color Gram 2 R 3-F,
bioMerieux) was added and the plates were left at room
temperature for 15 min to solubilize the dye. The optical
density of the alcohol–dye solution in each well was read at
wave length k = 570 (OD570) by using a microplate reader
(BioTek ELx800). Ampicillin was used as a reference
compound. The blank control wells without or with twofold
dilution of the tested compound added to TSB?HTMS
broth without bacterial suspension were incubated under the
same conditions. The experiments were performed in
triplicate.
Cytotoxicity assay
The vero cell culture from the American Type Culture
Collection (ATCC––84113001) was used in the experi-
ment. The minimum essential medium Eagle (MEM,
Sigma) media were supplemented with 10 % fetal bovine
serum (Sigma), 100 U ml-1 of penicillin, and 0.1 lg ml-1
of streptomycin (Polfa-Tarchomin, Poland). The cell cul-
ture was incubated at 37 C for 24 h in the 5 % CO2
atmosphere. A stock solution of N-ethyl-3-amino-5-oxo-4-
phenyl-2,5-dihydro-1H-pyrazole-1-carbothioamide at a
concentration of 50 mg ml-1 was dissolved in DMSO
(Sigma). The initial concentration of the examined com-
pound in the MEM medium was 500 lg ml-1.
100 ll of the vero cell culture prepared was plated into
96-well polystyrene microplates (NUNC) at a cell density
2 9 104 cells per well. After 24 h incubation at 37 C, the
media were removed and the cells were treated with a solution
of the tested compound diluted in the MEM medium including
2 % of serum. The following final concentrations were
applied: 3.15, 6.25, 12.5, 25, 50, 100, 200, and 500 lg ml-1.
At the same time, the cytotoxicity of solvents was examined.
The control cell culture was supplemented with media
including 2 % of serum only. The cell cultures were incubated
for 48 h at 37 C in the 5 % CO2 atmosphere. Cytotoxicity of
the tested compound was estimated using the MTT method,
described by Takenouchi and Munekata (1998). The MTT
method is a quantitative colorimetric toxicity test, based on the
transformation of yellow, soluble tetrazolium salts (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) to
purple-blue insoluble formazane. This process occurs natu-
rally in mitochondria of living cells. After 48 h incubation
with compounds, cell cultures were supplemented with 10 ll
of 5 mg ml-1 MTT solution per well, and further incubated
for 4 h at 37 C. Afterwards, 100 ll of water solution,
including 50 % dimethylformamide and 20 % SDS, per well
was added and after the all-night incubation the absorbance
was measured by the 96-well plastic plate reader (Organon
Teknika) at wavelengths of k = 540 and 620 nm. The med-
ium with DMSO at tested concentration range without the
tested compound served as control––it was not toxic to vero
cells line. The experiments were carried out in duplicates.
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Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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